| DOXFX | MKVFX | DOXFX / MKVFX | |
| Total Expense Ratio | 0.52 | 0.96 | 54% |
| Annual Report Gross Expense Ratio | 0.57 | 1.02 | 56% |
| Fund Existence | 4 years | 5 years | - |
| Gain YTD | 33.948 | 34.789 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 59.9B | 7.39B | 811% |
| Annual Yield % from dividends | 1.76 | 2.09 | 84% |
| Returns for 1 year | 29.41 | 26.29 | 112% |
| Returns for 3 years | 56.04 | 53.69 | 104% |
| Returns for 5 years | N/A | 64.19 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRAIX | 38.92 | N/A | N/A |
| T. Rowe Price Capital Appreciation I | |||
| BIPIX | 68.52 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| NEAGX | 54.87 | N/A | N/A |
| Needham Aggressive Growth Retail | |||
| RMDAX | 5.41 | N/A | N/A |
| Virtus Silvant Mid-Cap Growth A | |||
| GVIRX | 19.04 | N/A | N/A |
| Goldman Sachs US Eq Div and Premium Inv | |||